TY - JOUR
T1 - A randomised clinical trial of single or extended dosing ciprofloxacin versus no intervention for prevention of ventilation tube otorrhoea and obstruction (PreVenTO2)
AU - Wang, Luke Chenkan
AU - Phyland, Debra Jean
AU - Giddings, Charles Edward
N1 - Funding Information:
This research was investigator‐led and funded by the Department of ENT at Monash Health and did not receive additional funding from government or corporate sources
Publisher Copyright:
© 2021 John Wiley & Sons Ltd
PY - 2022/3
Y1 - 2022/3
N2 - Objectives: To determine the effectiveness of ciprofloxacin.3% antibiotic eardrops in preventing clinically significant postoperative otorrhoea and tube obstruction following grommet insertion in children. Design: Three-arm parallel assessor-blinded randomised controlled trial. Randomisation in 1: 1: 1 ratio to single intraoperative application of ciprofloxacin drops, extended 5 day postoperative application and no drops. Patients were assessed by blinded assessors at 6 weeks postoperatively. Setting: The study was conducted in a large tertiary health network in Melbourne, Australia. Participants: All children, 17 years and under, undergoing bilateral middle ear ventilation tube surgery with or without concurrent upper airway surgery for recurrent acute otitis media and chronic otitis media with effusion were approached. Main outcome measures: Presence of postoperative otorrhoea and ventilation tube obstruction at 6 weeks postoperatively. Results: Two-hundred and fifty-six paediatric patients completed the study with a median age of 4.02 years. One-hundred and fifty-three participants were male. Ear analysis (n = 512) showed intraoperative antibiotics were more effective than no drops in preventing otorrhoea (RR =.341, 95% CI.158–.738, NNT =11.25, p =.006). Postoperative antibiotics were more effective than no drops in preventing ventilation tube obstruction (RR =.424, 95% CI.193 to.930, NNT =14.7, p =.032). Conclusion: Intraoperative topical ciprofloxacin was effective at preventing early postoperative otorrhoea, and a prolonged course was effective at preventing ventilation tube obstruction. Future studies on this topic should seek to clarify whether particular subgroups of patients benefit more from prophylactic topical antibiotics and model for cost-effectiveness.
AB - Objectives: To determine the effectiveness of ciprofloxacin.3% antibiotic eardrops in preventing clinically significant postoperative otorrhoea and tube obstruction following grommet insertion in children. Design: Three-arm parallel assessor-blinded randomised controlled trial. Randomisation in 1: 1: 1 ratio to single intraoperative application of ciprofloxacin drops, extended 5 day postoperative application and no drops. Patients were assessed by blinded assessors at 6 weeks postoperatively. Setting: The study was conducted in a large tertiary health network in Melbourne, Australia. Participants: All children, 17 years and under, undergoing bilateral middle ear ventilation tube surgery with or without concurrent upper airway surgery for recurrent acute otitis media and chronic otitis media with effusion were approached. Main outcome measures: Presence of postoperative otorrhoea and ventilation tube obstruction at 6 weeks postoperatively. Results: Two-hundred and fifty-six paediatric patients completed the study with a median age of 4.02 years. One-hundred and fifty-three participants were male. Ear analysis (n = 512) showed intraoperative antibiotics were more effective than no drops in preventing otorrhoea (RR =.341, 95% CI.158–.738, NNT =11.25, p =.006). Postoperative antibiotics were more effective than no drops in preventing ventilation tube obstruction (RR =.424, 95% CI.193 to.930, NNT =14.7, p =.032). Conclusion: Intraoperative topical ciprofloxacin was effective at preventing early postoperative otorrhoea, and a prolonged course was effective at preventing ventilation tube obstruction. Future studies on this topic should seek to clarify whether particular subgroups of patients benefit more from prophylactic topical antibiotics and model for cost-effectiveness.
UR - http://www.scopus.com/inward/record.url?scp=85121343911&partnerID=8YFLogxK
U2 - 10.1111/coa.13887
DO - 10.1111/coa.13887
M3 - Article
C2 - 34758186
AN - SCOPUS:85121343911
SN - 1749-4478
VL - 47
SP - 287
EP - 294
JO - Clinical Otolaryngology
JF - Clinical Otolaryngology
IS - 2
ER -